![]() |
|
|
Vol. 283, Issue 1, 265-273, 1997
Department of Pharmacology, University of Medicine and Dentistry of
New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey
(D.J.W., D.S.G., M.J.N.), and
Intramural Research Support Program, SAIC
Frederick, National Cancer Institute, Frederick Cancer Research and
Development Center, Frederick, Maryland (G.S.)
A series of substituted aminoguanidines and amino-substituted
isothioureas have been examined as inhibitors of nitric oxide (NO)
synthase (NOS) isoforms. Each of the agents produced a time- and
concentration-dependent inactivation of the NO-forming activity of the
affinity-purified NOS isoforms. These inactivations required exposure
of NOS to the drug under conditions that supported catalysis, consistent with the proposal that they act as alternate substrate, mechanism-based inactivators. Of the aminoguanidines examined, 2-ethylaminoguanidine was the most efficient inactivator, exhibiting vs. iNOS an apparent KI value of 120 µM as measured at 100 µM arginine and a
kinact max value of 0.48 min
1 and
thus an apparent second-order rate constant for inactivation of 4.0 mM
1min
1. 2-Ethylaminoguanidine displayed a high
isoform selectivity for the iNOS compared with the nNOS and eNOS
isoforms. 2-Ethylaminoguanidine inactivated NO synthetic activity in
cytokine-induced RAW 264.7 cells as measured at 100 µM extracellular
arginine with an apparent KI value of 55 µM
and a kinact max value of 0.09 min
1. The inactivated RAW 264.7 cell NO synthetic
capability was restored over a 3-hr period after drug removal to a
value 60% of its pretreatment value. This recovery occurred despite
the presence of cycloheximide sufficient to inhibit protein synthesis
by >99%. 1-Amino-S-methylisothiourea by contrast with the
aminoguanidines was identified as a mechanism-based inactivator
selective for the nNOS isoform. In contrast to S-isopropylisothiourea, which was found to be both cell penetrant and reversible,
1-amino-S-methylisothiourea appeared cell impermeable and inhibited NOS
enzyme "irreversibly."
This article has been cited by other articles:
![]() |
K. L. Cummings and R. L. Tarleton Inducible Nitric Oxide Synthase Is Not Essential for Control of Trypanosoma cruzi Infection in Mice Infect. Immun., July 1, 2004; 72(7): 4081 - 4089. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. KIROYCHEVA, F. AHMED, G. M. ANTHONY, C. SZABO, G. J. SOUTHAN, and N. BANK Mitogen-Activated Protein Kinase Phosphorylation in Kidneys of {beta}s Sickle Cell Mice J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1026 - 1032. [Abstract] [Full Text] |
||||
![]() |
K. A. Fagan, R. C. Tyler, K. Sato, B. W. Fouty, K. G. Morris Jr., P. L. Huang, I. F. McMurtry, and D. M. Rodman Relative contributions of endothelial, inducible, and neuronal NOS to tone in the murine pulmonary circulation Am J Physiol Lung Cell Mol Physiol, September 1, 1999; 277(3): L472 - L478. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Roberts, R. J. Barnard, A. Jasman, and T. W. Balon Acute exercise increases nitric oxide synthase activity in skeletal muscle Am J Physiol Endocrinol Metab, August 1, 1999; 277(2): E390 - E394. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sato, D. M. Rodman, and I. F. McMurtry Hypoxia inhibits increased ETB receptor-mediated NO synthesis in hypertensive rat lungs Am J Physiol Lung Cell Mol Physiol, April 1, 1999; 276(4): L571 - L581. [Abstract] [Full Text] [PDF] |
||||